(Q36965015)

17 August 2017

1 reference

title

Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis (English)

1 reference

17 August 2017

0 references

0 references

Laurence S Harbige

1

1 reference

17 August 2017

Mohammad K Sharief

series ordinal

2

1 reference

17 August 2017

publication date

1 October 2007

1 reference

British Journal of Nutrition

17 August 2017

published in

1 reference

17 August 2017

volume

98 Suppl 1

1 reference

17 August 2017

page(s)

S46-53

1 reference

Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

A review of the aetiology of multiple sclerosis: an ecological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Diet and the geographical distribution of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Multiple sclerosis: novel perspectives on newly forming lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

The essentiality of n-3 fatty acids for the development and function of the retina and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Effect of low saturated fat diet in early and late cases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

In vitro study of mediators of inflammation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: Implications for pathogenesis and handling of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

The accumulation of arachidonate and docosahexaenoate in the developing rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Diverse, region-specific effects of addition of arachidonic and docosahexanoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Serum fatty acids in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Immunopathogenesis of multiple sclerosis: the role of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Progress in determining the causes and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Insights into the aetiology and pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

Polyunsaturated fatty acid supplementation stimulates differentiation of oligodendroglia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Temporal analysis of growth factor mRNA expression in myelinating rat brain aggregate cultures: increments in CNTF, FGF-2, IGF-I, and PDGF-AA mRNA are induced by antibody-mediated demyelination

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Multiple sclerosis: effect of gamma linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Multiple sclerosis: occurrence of myelin basic protein peptide-reactive T cells in healthy family members

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Multiple sclerosis and nutrition

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

The Ratio of Trienoic: Tetraenoic Acids in Tissue Lipids as a Measure of Essential Fatty Acid Requirement

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Multiple sclerosis: the lipid relationship

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

SERUM FATTY ACIDS IN MULTIPLE SCLEROSIS

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF beta

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Relationship between plasma and lymphocyte linoleate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Linoleate and fatty acid patterns of serum lipids in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Prevention of experimental autoimmune encephalomyelitis in Lewis rats by a novel fungal source of gamma-linolenic acid

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Linoleate and fatty acid compositions in the serum lipids of Japanese patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Linoleic acid levels in white blood cells, platelets, and serum of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Red blood cell fatty acids in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Review: cytokines and the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Further studies on platelet adhesiveness and serum cholesteryl linoleate levels in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Fatty acid patterns of red blood cell phospholipids in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Double-blind Trial of Linoleate Supplementation of the Diet in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Multiple Sclerosis: Twenty Years on Low Fat Diet

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies?

1 reference

https://api.crossref.org/works/10.1017%2FS0007114507833010

7 January 2021

10.1017/S0007114507833010

Identifiers

DOI

1 reference

17 August 2017

1 reference